OPT opthea limited
Add to My Watchlist 0.00% ! 60.0¢

The DFA Discussion, page-77

  1. whytee
    17,570 Posts.
    lightbulb Created with Sketch. 2521
    clock Created with Sketch.
    25/03/25
    17:50
    Post #: 78410424
    It's generally accepted that Eyelea is more potent than Lucentis because of it's additional mechanism of action. In the phase 2b trial the combination of Lucentis with OPT302 was superior to Lucentis alone. It's likely that would be replicated.
    OPT Price at posting: 60.0¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS High-Grade Gold Hits Extend Major Lodes at Kpali Prospect in Ghana
right-arrow Created with Sketch.
NEWS FBR Executes Engineering Service Agreement with Samsung Heavy Industries
right-arrow Created with Sketch.
NEWS Pathological Complete Response Recorded in ACCENT Trial of Advanced Pancreatic Cancer
right-arrow Created with Sketch.
NEWS Agreement for Sale of Mount Mason Project to Gold Valley Yilgarn
right-arrow Created with Sketch.
NEWS Bonanza Dittmer Drilling Hits 221g/t Gold in Stage 5 Intersection
right-arrow Created with Sketch.
LU7 Lithium Universe Acquires Global Rights to Transformative Solar Panel Recycling Technology
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
60.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $738.7M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
OPT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.